CIAM
KYTX icon

Caitong International Asset Management’s Kyverna Therapeutics KYTX Stock Holding History

Caitong International Asset Management’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Sell
129
-1,995
-94% -$17.7K ﹤0.01% 1511
2026
Q1 		$18.3K Buy
+2,124
New +$17.7K ﹤0.01% 1002
2025
Q2 		– Sell
-1,827
Closed -$3.53K – 2568
2025
Q1 		$3.53K Buy
+1,827
New +$5.4K ﹤0.01% 1124

Other funds holding KYTX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Caitong International Asset Management's KYTX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Kyverna Therapeutics (KYTX) stake by 94% in Q2 2026, selling an estimated $17.7K and leaving 129 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Caitong International Asset Management first reported a position in KYTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $18.3K in Q1 2026. 59 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Caitong International Asset Management held 129 shares of Kyverna Therapeutics worth $1.15K as of Q2 2026.
  • Caitong International Asset Management sold 1,995 Kyverna Therapeutics shares in Q2 2026, an estimated $17.7K.
  • Kyverna Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1511 holding.
  • Caitong International Asset Management first reported a position in Kyverna Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Caitong International Asset Management's Kyverna Therapeutics position peaked at $18.3K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.